KALA BIO, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
KALA BIO, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2017 to Q3 2024.
  • KALA BIO, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.78M, a 15.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.78M -$324K -15.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.86M Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.95M +$1.94M +32317% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.03M +$2.01M +12556% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2.1M +$2.07M +6082% Sep 30, 2023 10-Q 2023-11-13
Q1 2023 $6K -$1.38M -99.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $16K -$1.28M -98.8% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $34K -$27.3M -99.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $51K -$27.9M -99.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.39M -$27.2M -95.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.3M -$26.6M -95.3% Dec 31, 2021 10-K 2023-03-03
Q3 2021 $27.3M -$1.01M -3.55% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $28M -$876K -3.04% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $28.5M -$766K -2.61% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $27.9M -$1.93M -6.47% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $28.3M -$1.9M -6.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $28.8M -$1.88M -6.13% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $29.3M -$1.84M -5.89% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $29.8M +$215K +0.73% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $30.2M +$30.1M +22990% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $30.7M +$30.5M +13490% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $31.1M +$30.8M +9632% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $29.6M +$29.2M +7059% Dec 31, 2018 10-K 2020-02-12
Q3 2018 $131K Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $226K Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $320K Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $413K Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.